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Rapid Communication
670nm Laser Light and EGCG Complementarily Reduce
Amyloid-b Aggregates in Human Neuroblastoma Cells:
Basis for Treatment of Alzheimer’s Disease?
Andrei P. Sommer, Ph.D.,1 Jan Bieschke, Ph.D.,2 Ralf P. Friedrich, Ph.D.,2 Dan Zhu, M.Sc.,1
Erich E. Wanker, Ph.D.,2 Hans J. Fecht, Ph.D.,1,3 Derliz Mereles, M.D.,4 and Werner Hunstein, M.D.5
Abstract
Objective: The aim of the present study is to present the results of in vitro experiments with possible relevance in
the treatment of Alzheimer’s disease (AD). Background Data: Despite intensive research efforts, there is no
treatment for AD. One root cause of AD is the extra- and intracellular deposition of amyloid-beta (Ab) fibrils in
the brain. Recently, it was shown that extracellular Ab can enter brain cells, resulting in neurotoxicity. Methods:
After internalization of Ab42 into human neuroblastoma (SH-EP) cells, they were irradiated with moderately
intense 670-nm laser light (1000 Wm - 2) and/or treated with epigallocatechin gallate (EGCG). Results: In irra-
diated cells, Ab42 aggregate amounts were significantly lower than in nonirradiated cells. Likewise, in EGCG-
treated cells, Ab42 aggregate amounts were significantly lower than in non-EGCG-treated cells. Except for the
cells simultaneously laden with Ab42 and EGCG, there was a significant increase in cell numbers in response to
laser irradiation. EGCG alone had no effect on cell proliferation. Laser irradiation significantly increased ATP
levels in Ab42-free cells, when compared to nonirradiated cells. Laser-induced clearance of Ab42 aggregates
occurred at the expense of cellular ATP. Conclusions: Irradiation with moderate levels of 670-nm light and
EGCG supplementation complementarily reduces Ab aggregates in SH-EP cells. Transcranial penetration of
moderate levels of red to near-infrared (NIR) light has already been amply exploited in the treatment of patients
with acute stroke; the blood–brain barrier (BBB) penetration of EGCG has been demonstrated in animals. We
hope that our approach will inspire a practical therapy for AD.
Introduction
One root cause in Alzheimer’s disease (AD) isamyloid-beta (Ab)1, a hydrophobic proteolytic fragment
that forms dense networks of fibers in the brain of patients
with AD. In AD, Ab forms large extracellular deposits. Re-
cently, it was shown that extracellular Ab can enter the cell,
resulting in neurotoxicity.2,3 Earlier, we demonstrated that
epigallocatechin gallate (EGCG), a polyphenol extracted from
green tea, can prevent the formation of fibrillar deposits of Ab
and other amyloidogenic proteins.4,5 When added to mam-
malian cells, the compound converts Ab fibrils to nontoxic
structures and reduces intracellular Ab aggregate amounts.6
Oral administration of green tea extract arrested Ab deposi-
tion in an AD mouse model,7 and reversed amyloid deposi-
tion in the heart in a case of lambda light-chain amyloidosis.8
The penetration of EGCG across the blood–brain barrier (BBB)
was confirmed in various animal models.9,10
Recently, we showed that irradiation of EGCG-exposed
HeLa cells with 670-nm laser light is instrumental in forcing
the cells to rapidly uptake high amounts of EGCG and other
cytostatic compounds.11 The laser light was applied in a linear
scanning mode at a frequency of 1 Hz with the basic irradia-
tion parameters irradiance and fluence adjusted to the bios-
timularory windows12 communicated by us earlier: 1$103
Wm - 2 and 1$104 Jm - 2, respectively. At 45lM EGCG 1 min
intermittent irradiation following an incubation period of 3 h
resulted in a reduction in cell numbers by two-thirds com-
pared to a reduction by one-third with EGCG alone. EGCG is
described to kill tumor cells by telomere fragmentation.13
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In other words, EGCG, acting here as an anticancer com-
pound, performed its function intracellularly. Interestingly,
the anticancer effect is not restricted to the pure compound
EGCG. As we previously demonstrated, even sterile-filtered
green tea had a profound cytostatic effect on HeLa cells.14 The
function of the intermittent irradiation mode is to facilitate the
transport of the active compound into cells via transmem-
brane convection, a mechanism based on the interaction of
670-nm light with nanoscopic interfacial water layers on sur-
faces.15,16 The cause of the convective flow across the plasma
membrane is the simultaneous modulation of the density and
viscosity of the nanoscopic interfacial water layers prevailing
between intracellular surfaces (macromolecules and organ-
elles). The effect is expected to be most pronounced in cells
that are rich in mitochondria.17 Previously, we reported that
the combination of topically applied EGCG and moderate
levels of 670-nm light has beneficial effects in vivo, in particular
in skin rejuvenation, where we exploited the capability of
EGCG to act as a scavenger of reactive oxygen species (ROS).18
We anticipated that irradiation with 670-nm light is possibly
also useful in forcing brain cells to uptake EGCG, on the one
hand, and to increase ATP levels in Ab-stressed brain cells, on
the other hand—both effects supposed to be beneficial in
improving the condition of patients with AD. For clarification,
we exposed human neuroblastoma (SH-EP) cells loaded with
Ab42 to 670-nm laser light and EGCG.
Material and Methods
Synthetic Ab42 was labeled with the fluorescent dye Alexa
633-NHS (Invitrogen) overnight at 4C at a 1:1 M ratio under
the conditions specified by the manufacturer. Labeled pep-
tide was purified by gel filtration in 10 mM NH4OH and
filtered through a 30 kD membrane filter (Millipore) to re-
move aggregated material. SH-EP cells (25.000 cells per well)
that express the green fluorescent protein (GFP)-tagged nu-
clear histone protein H2B, were cultured in DMEM supple-
mented with 4.5 g/L d-glucose, 10% fetal bovine serum,
100 IU/mL penicillin and 100lg/mL streptomycin at 37 C/
5 % CO2 in 24-well plates. After 5 h, labeled Ab42 was added
to the culture medium in half of the wells to a final
concentration of 200 nM, whereas equivalent amounts of
buffer were added to control cells. Cells were then incubated
overnight.
To test the effects of EGCG treatment and laser irradiation
on the clearance of aggregated intracellular Ab42, we added
fluorescently labelled Ab42 to the culture medium containing
the SH-EP cells.3 Cells were then incubated for 24 h, before
the culture medium was exchanged to remove Ab42 from
outside the cells. The cells were divided in six groups: (1)
controls, (2) supplemented with 10 lM EGCG, (3) supple-
mented with 40 lM EGCG, (4) treated with Ab42, (5) treated
with Ab42 and 10 lM EGCG, (6) treated with Ab42 and 40 lM
EGCG. Four wells of each group were subjected to laser
treatment, whereas four wells remained untreated. Laser
treatment (power 33 mW, beam geometry 2 mm x 15.5 mm,
local irradiance 1$103 Wm - 2 and mean fluence 1$104 Jm - 2)
was performed manually for 1 min per well (area 1.9 cm2) in
a linear scanning mode at a frequency of 1 Hz (controlled by
a metronome), according to the previously communicated
protocol.11 Cells were then incubated further for 24 h.
Next, the well plates were placed into a high-content
screening (HCS) cell analysis system (Arrayscan VTI, Ther-
mo Scientific). In groups 1 to 6 the analysis comprised cell
proliferation and quantification of the Ab42 aggregate
amounts within the cells. The working principle of the HCS
analysis is described in detail elsewhere.19 Briefly, the com-
partmental analysis module of the ArrayScan VTI software
was used to identify nuclei by GFP fluorescence, to fit cell
dimensions and to identify Ab42 aggregates by Alexa 633
fluorescence (cf. Fig. 1). Non-aggregate fluorescence back-
ground was discarded from the analysis and fluorescence
signals were normalized to cell numbers. Four independent
wells with *4500 cells per well were analyzed. Statistical
significance was evaluated by Student’s t test. * Marks
p< 0.05. Higher significance levels are marked by ** as indi-
cated. All results are represented as mean values; error bars
signify standard deviations. Furthermore, we checked for
possible effects of the 670-nm laser light on the bleaching of
the labeled Ab42 aggregates. For this, we irradiated half of
the previously nonirradiated wells using the protocol men-
tioned above, and quantified Ab-Alexa 633 fluorescence
signals directly after irradiation. Importantly, a bleaching
effect could not be observed.
FIG. 1. Fluorescence mi-
croscopy images of SH-EP
cells with Ab42 aggregates.
Left: nuclear staining, right:
Ab42-Alexa 633 signal. Cell
bodies (red contour lines),
nuclei (blue contour lines),
and Ab42 aggregates (yellow)
were identified by the image
analysis software.
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In order to test the effect of the laser light on ATP levels,
SH-EP cells were seeded in 24-well plates and divided into
two groups, controls and irradiated, conforming to the
aforementioned parameters. We also incubated rat pheo-
chromocytoma (PC12) cells with aggregated Ab42
5 for 24 h,
and subjected them to the same laser and EGCG treatment
regime as described above. After irradiation, cells were in-
cubated for further 48 h and cellular ATP content was
quantified. Cellular ATP content was determined after lysing
the cells (Tris-HCl 200 mM pH 7.7, NaCl 2 M, EDTA 20 mM,
Triton X-100 0.2%) for 1 h at 4C. Supernatants were cleared
by centrifugation (14 krpm, 15 min, 4C). Cellular ATP con-
tent was quantified using a luciferin/luciferase luminescence
kit (A 22066, Invitrogen) and compared to standard ATP
dilution series.
Results
A representative fluorescence microscopy image of Ab42
aggregates in SH-EP cells is shown in Fig. 1. Figure 2 shows
the results of the analysis for the Ab42 aggregate amounts in
groups 1 to 6. EGCG treatment reduced the intracellular
Ab42 aggregate amounts in SH-EP cells by up to 50% in a
concentration-dependent manner. A similar reduction had
been observed earlier in Chinese hamster ovary cells that
overexpressed Ab (7PA2 cells).6 Coincidentally, laser irra-
diation significantly reduced intracellular Ab42 aggregate
amounts, when compared to nonirradiated cells (Fig. 2). We
started with the working hypothesis that laser irradiation
would increase the uptake of EGCG and thereby further
reduce intracellular Ab aggregates. Surprisingly, the re-
duction was observed even in laser-irradiated cells that
were not treated with EGCG. We therefore conclude that
Ab aggregate reduction by laser irradiation does not require
prior treatment by EGCG. Rather, both processes appear to
affect the removal of Ab aggregates complementarily.
Figure 3 illustrates the effect of the laser light on the
proliferation of the SH-EP cells. We quantified the prolifer-
ative effect in the presence and absence of Ab42 aggregates
by counting cell numbers 24 h after irradiation. Similar to
what has been observed in other model systems,12 irradiation
at 670 nm significantly increased cell proliferation, in our case
by *20%. Concomitant treatment with EGCG did not affect
cell proliferation in cells that did not contain Ab42 aggregates.
Remarkably, the proliferative effect was most pronounced in
Ab42-free cells. Interestingly, the proliferative effect of the
light depended on the specific load of the cells. Relative to
groups 1 to 3 (starting from the left in Fig. 3) the proliferation
FIG. 2. Quantification of the Ab42 aggregate
fluorescence signals. Fluorescence intensity is
proportional to the Ab42 aggregate amounts.
Fluorescence is restricted to the wells con-
taining SH-EP cells laden with Ab42. Cells
incubated with Ab42 (+Ab42) showed fluo-
rescence signals. Cells incubated without Ab42
(-Ab42) showed no fluorescence. Laser irradi-
ation significantly reduced intracellular ag-
gregate load. Analysis of four independent
wells per sample with *4500 cells per well:
**p< 0.002, *p< 0.05.
FIG. 3. 670-nm laser irradiation accelerates
cell proliferation. Proliferation is reduced in
Ab42 - and EGCG-treated SH-EP cells. Ana-
lysis of four independent wells: **p< 0.02,
*p< 0.05.
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in group 4 (cells laden with Ab42) was lower. And in groups 5
and 6 (cells double-burdened with EGCG and Ab42) a pro-
liferative effect was totally absent. This finding might have
clinical relevance (c.f. Discussion section).
We therefore conclude that clearance of intracellular Ab
aggregates is performed at the expense of cell proliferation—
either the Ab aggregates inhibit cellular metabolism or
clearance of the aggregates redirects metabolic resources
away from proliferation. To explore whether the process of
Ab clearance inhibited cellular metabolism, we quantified
the ATP content of the cells under the different treatment
conditions. For this, we irradiated two neuronal model cell
lines, SH-EP and PC12 in the absence of Ab42, using the
previously established protocol.11 In SH-EP cells we found a
20% increase in ATP levels (Fig. 4a), corresponding to the
increase in cell proliferation (Fig. 3). PC12 cells presented a
small increase in ATP levels, in the absence of further treat-
ment (Fig. 4a). However, PC12 cells that were challenged
with Ab42 aggregates and then treated with a combination of
laser irradiation and EGCG showed a significant reduction in
ATP levels when compared to Ab42-challenged but untreated
cells (Fig. 4b).
Discussion
The principal result of the present study is that 670-nm
laser light and EGCG complementarily reduce intracellular
Ab42 aggregate amounts (Fig. 2). In interpreting this result, it
is instructive to establish a connection with the result of Fig.
3 (increase in cell proliferation). It is well documented that
exposure to 670-nm light at irradiance and fluence ranges
described by the biostimulatory windows12 stimulates cell
proliferation and mitochondrial metabolism, which was also
observed in our model system (Fig. 4a). According to current
photobiology models, cell proliferation is primarily caused
by a boost in ATP levels in the mitochondria, with cyto-
chrome c oxidase as a receptor for 670-nm light, as suggested
by several reports.20–25 Moreover, intermittent laser treat-
ment with irradiation parameters adjusted to the biostimu-
latory windows12 was found to facilitate the uptake of drugs
such as EGCG by HeLa cells.11
A dominance of the latter effect in our model system
would manifest itself in potentiating the EGCG effect. In-
stead, we observed that both treatments affect Ab load
complementarily. Consequently, it is tempting to assume
that EGCG transport into SH-EP cells by intermittent laser
irradiation is less pronounced than for HeLa cells. It is now
easy to see the reason for the apparent inefficiency of the
intermittent irradiation mode. Inspection of Fig. 3 (groups 1
to 3) reveals that EGCG had only a minimal effect on the
proliferation of nonirradiated SH-EP cells, as opposed to a
massive inhibition on that of nonirradiated HeLa cells.11
From Fig. 2, it is clear that EGCG has crossed the plasma
membrane (otherwise it could not reduce intracellular Ab42
levels). Comparison with the impact of EGCG on HeLa
cells11 displays differences in the action spectrum of the
compound in general, and in its cytostatic potency in par-
ticular. In general, the efficacy of transmembrane convection
depends upon both the cell’s permeability to water and the
fraction of intracellular water prevalent as nanoscopic in-
terfacial water layers on hydrophilic surfaces. Notably, mi-
tochondria contain considerable amounts of nanoscopic
interfacial water layers.17 Inspection of Fig. 1 reveals that
internalized Ab42 tends to condensate into a shell around the
nucleus. A precondition for the establishment of the shell is
passage across the plasma membrane and radial diffusion
toward the nucleus. En route to the nucleus, the hydrophobic
Ab42, known to accumulate in intracellular vesicular struc-
tures,2,3 might compete for proximal surfaces and contribute
to a depletion of hydrophilic intracellular surfaces—the res-
ervoirs of nanoscopic interfacial water layers.
From considering the stimulation of mitochondrial me-
tabolism by the laser irradiation (Fig. 4) it is clear that the
laser light plays a strong role in reducing Ab aggregate load.
We observed that cellular ATP levels were increased by laser
irradiation, but that this increase was diminished in the
presence of Ab aggregates. Thus, light-induced removal of
Ab aggregates seems to lower ATP levels (Fig. 4). Of par-
ticular interest in this context is the absence of a proliferative
effect of the laser light in double-burdened cells (Fig. 3,
groups 5 and 6). Therefore, in the course of therapy, EGCG
treatment prior to light treatment could be counterproduc-
tive. EGCG treatment of cells in the absence of Ab had no
significant impact on either cell proliferation or ATP levels
(Figs. 3 and 4b). In contrast, ATP and cell proliferation were
lowered when Ab aggregates were removed by EGCG/
FIG. 4. ATP quantification in irradiated
and nonirradiated SH-EP and PC12 cells: (a)
ATP levels without Ab42 treatment:
**p < 0.003, n= 12; (b) ATP levels of PC12 cells
in the presence of Ab42 after EGCG treat-
ment: **p< 0.001, *p< 0.05, n= 9.
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irradiation treatment. Consequently, we feel justified in as-
suming that the anti-Ab effect of the laser irradiation was
performed at the expense of the cell’s own currency: ATP.
However, there are uncertainties in our apparently
straightforward experiments, which should be clearly men-
tioned. In other models, proliferative effects are related to a
moderate increase in ROS in the mitochondria.26,27 However,
an increase in ROS levels provoked by the applied laser light
seems implausible. EGCG is a potent ROS scavenger,28 so an
increase in ROS levels should oxidize EGCG and result in a
decrease in EGCG activity. The ROS scavenging capacity of
EGCG was recently exploited in preventing Ab-induced ROS
accumulation in primary cortical neurons.29 Cell prolifera-
tion might even be controlled by an externally imposed
metabolism (nutrient uptake) via intermittent irradiation,11
possibly also observed in HEp-2 cells.30 Of fundamental in-
terest is the nature of the mechanism by which Ab is cleared
in response to 670-nm light irradiation—presumably, a cel-
lular program fueled by the light. Our experiments cannot
determine whether the light stimulates known pathways of
protein homeostasis such as chaperone activity, ubiquitin-
proteasome system response or autophagocytosis.31 All of
these pathways could account for ATP depletion but we
cannot fully exclude an unknown photochemical effect in-
volving mitochondrial ROS activated by 670-nm light.
Figure 5 illustrates the synergistic interplay between the
chemical and physical mechanism of photobiomodulation. In
both the irradiation parameters coincide with those found by
the Mester group to accelerate wound healing.32 In principle,
it should be possible to combine ATP and/or ROS-related
metabolic stimulation with the external modulation of na-
noscopic interfacial water layers by optimizing irradiation
parameters, an attractive challenge in photomedicine, which
reflects the intense discussion on the subject.33
Our laboratory experiment receives possible therapeutic
relevance from two sides: Animal experiments indicate the
penetration of EGCG across the BBB.9,10 Coincidentally,
moderate irradiances (*kWm - 2) of red to NIR light, in-
cluding 670 nm, penetrate several centimeters of tissue, in-
cluding the cranial bone, delivering therapeutically relevant
irradiances. For example, in the case of extreme cardiac
dysrhythmia with characteristic symptoms of angina pec-
toris, 30 min transcostal cardiac stimulation with a battery of
seven 670-nm lasers, each 50 mW, pulse frequency 1 Hz,
resulted in an instant normalization of the heart rhythm and
total disappearance of the angina symptoms (A.P. Sommer,
personal communication). Three minutes’ irradiation of the
heart of rats and dogs with NIR laser light (local irradiance
and fluence at the myocardial level 60 Wm- 2, 1.08$104 Jm - 2,
respectively) was already reported to reduce scar tissue
formation after myocardial infarction.34 The transcranial
transmission of red to NIR light delivered by an array of
light-emitting diodes has been recently illustrated in the
treatment of chronic, traumatic brain injury.35 A represen-
tative review of the literature on the use of moderate
irradiances of red to NIR light in the treatment of acute
stroke both in humans and animal models can be found in
the literature.36 Therefore, amyloid deposits in internal or-
gans, including brain may be accessible to the combination of
irradiation and drug treatment that reduced Ab aggregate
load in our cellular model. However, in vivo transfer of the
irradiance level found to be effective in vitro at 670 nm needs
careful adjustment. In view of the documented clinical evi-
dence for the deep tissue penetration of 670-nm light,37 and
the reported clinical success in transcranial application of
combinations of red and NIR light, it appears reasonable to
extend the current tests and investigate the clearance of Ab
by combinations of wavelengths, in particular 670 nm and
NIR. Expectedly, the functional interplay and complemen-
tary effects of laser irradiation and drug treatment are not
restricted to the drug EGCG, but might also be an interesting
combination for other therapeutic compounds. In view of the
encouraging results, it is clear that further study is now
necessary.
Conclusions
Irradiation with moderate levels of 670-nm light and
EGCG supplementation complementarily reduces Ab ag-
gregate amounts in human neuroblastoma cells. Combina-
tion therapy is most effective when components are
combined that have complementary mechanisms of action. It
can be expected that EGCG is not the only compound which,
in combination with 670-nm laser light, reduces Ab. Gen-
eralization of the complementarity principle between light
and drug may open totally new perspectives for the treat-
ment of AD.
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